Insider · CIK 0001612372

Watson W. Mark

Reports to the SEC for 8 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001612372

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-16	VXRTVaxart, Inc.A Award	Director	AAward	+39.4K sh	—	—	173,525
2026-07-16	VXRTVaxart, Inc. · Stock Options (right to buy)A Award	Director	AAward	+78.7K sh	—	—	78,700
2026-05-22	VXRTVaxart, Inc.P Purchase	Director	PPurchase	+10K sh	$0.65	+$6,530	134,125
2025-11-17	VXRTVaxart, Inc.P Purchase	Director	PPurchase	+15K sh	$0.41	+$6,150	119,125
2025-11-17	VXRTVaxart, Inc.P Purchase	Director	PPurchase	+5,000 sh	$0.41	+$2,035	124,125
2025-07-29	VXRTVaxart, Inc.P Purchase	Director	PPurchase	+10K sh	$0.41	+$4,050	104,125
2025-06-13	VXRTVaxart, Inc.A Award	Director	AAward	+16K sh	—	—	94,125
2025-06-13	VXRTVaxart, Inc. · Stock Option (right to buy)A Award	Director	AAward	+95.4K sh	—	—	95,400
2024-06-18	VXRTVaxart, Inc.P Purchase	Director	PPurchase	+20K sh	$0.68	+$13.6K	78,125
2024-06-11	VXRTVaxart, Inc.A Award	Director	AAward	+16K sh	—	—	58,125
2024-06-11	VXRTVaxart, Inc. · Stock Option (right to buy)A Award	Director	AAward	+95.4K sh	—	—	95,400
2023-06-26	VXRTVaxart, Inc.A Award	Director	AAward	+7,375 sh	—	—	42,125
2023-06-26	VXRTVaxart, Inc. · Stock Option (right to buy)A Award	Director	AAward	+44.2K sh	—	—	44,224
2022-12-28	VXRTVaxart, Inc.P Purchase	Director	PPurchase	+20K sh	$0.76	+$15.1K	20,000
2022-08-04	VXRTVaxart, Inc.A Award	Director	AAward	+14.8K sh	—	—	14,750
2022-08-04	VXRTVaxart, Inc. · Stock Option (right to buy)A Award	Director	AAward	+88.4K sh	—	—	88,448
2022-03-22	BIODELIVERY SCIENCES INTERNATIONAL INCJ Other	Director	JOther	−90.7K sh	—	—	0
2022-03-22	BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−22.7K sh	—	—	0
2022-03-22	BIODELIVERY SCIENCES INTERNATIONAL INCStock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−54.7K sh	—	—	0
2022-03-22	BIODELIVERY SCIENCES INTERNATIONAL INCStock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−85.8K sh	—	—	0
2022-01-27	BIODELIVERY SCIENCES INTERNATIONAL INCM Exercise/Conversion	Director	MExercise/Conversion	+7,684 sh	—	—	90,663
2022-01-27	BIODELIVERY SCIENCES INTERNATIONAL INCStock Options (right to buy)A Award	Director	AAward	+85.8K sh	$3.66	+$314K	85,760
2022-01-27	BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsA Award	Director	AAward	+15.4K sh	—	—	15,369
2022-01-27	BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−7,684 sh	—	—	7,685
2021-08-27	SYKES ENTERPRISES INCD Disposition to Issuer	Director	DDisposition to Issuer	−13.5K sh	—	—	0
2021-08-06	BIODELIVERY SCIENCES INTERNATIONAL INCM Exercise/Conversion	Director	MExercise/Conversion	+30K sh	—	—	82,979
2021-08-06	BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	15,000
2021-05-19	SYKES ENTERPRISES INCA Award	Director	AAward	+694 sh	$41.43	+$28.8K	11,409
2021-02-22	SYKES ENTERPRISES INCA Award	Director	AAward	+181 sh	$41.93	+$7,589.33	10,715
2021-02-16	SYKES ENTERPRISES INCA Award	Director	AAward	+1,000 sh	$42.86	+$42.9K	10,534
2020-12-22	INTIInhibitor Therapeutics, Inc. · Common Stock OptionA Award	Director	AAward	+1.31M sh	—	—	1,306,452
2020-11-23	SYKES ENTERPRISES INCA Award	Director	AAward	+181 sh	$37.90	+$6,859.9	9,534
2020-11-13	SYKES ENTERPRISES INCA Award	Director	AAward	+1,000 sh	$37.20	+$37.2K	9,353
2020-08-24	SYKES ENTERPRISES INCA Award	Director	AAward	+181 sh	$33.42	+$6,049.02	8,353
2020-08-17	BIODELIVERY SCIENCES INTERNATIONAL INCS Sale	Director	SSale	−13K sh	$5.18	−$67.3K	52,979
2020-08-13	SYKES ENTERPRISES INCA Award	Director	AAward	+1,000 sh	$34.36	+$34.4K	8,172
2020-08-07	BIODELIVERY SCIENCES INTERNATIONAL INCM Exercise/Conversion	Director	MExercise/Conversion	+30K sh	—	—	65,979
2020-08-07	BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	45,000
2020-05-22	SYKES ENTERPRISES INCA Award	Director	AAward	+181 sh	$25.95	+$4,696.95	7,172
2020-05-13	SYKES ENTERPRISES INCA Award	Director	AAward	+1,000 sh	$25.00	+$25K	6,991
2020-03-30	SYKES ENTERPRISES INCS Sale	Director	SSale	−3,000 sh	$26.10	−$78.3K	5,991
2020-03-20	INTIInhibitor Therapeutics, Inc. · Common Stock OptionA Award	Director	AAward	+1.5M sh	—	—	1,500,000
2020-02-24	SYKES ENTERPRISES INCA Award	Director	AAward	+181 sh	$35.67	+$6,456.27	8,991
2020-02-21	SYKES ENTERPRISES INCA Award	Director	AAward	+983 sh	$35.95	+$35.3K	8,810
2019-12-12	INTIInhibitor Therapeutics, Inc.P Purchase	Director	PPurchase	+500 sh	$0.06	+$30.95	1,054,100
2019-11-22	SYKES ENTERPRISES INCA Award	Director	AAward	+181 sh	$34.92	+$6,320.52	7,827
2019-11-21	SYKES ENTERPRISES INCA Award	Director	AAward	+984 sh	$35.27	+$34.7K	7,646
2019-08-22	SYKES ENTERPRISES INCA Award	Director	AAward	+181 sh	$29.19	+$5,283.39	6,662
2019-08-21	SYKES ENTERPRISES INCA Award	Director	AAward	+984 sh	$28.89	+$28.4K	6,481
2019-08-13	BIODELIVERY SCIENCES INTERNATIONAL INCM Exercise/Conversion	Director	MExercise/Conversion	+24.7K sh	—	—	35,979

Recent filings

Accepted (ET)
Jul 174
Watson W. Mark0001437749-26-023808
SEC(opens sec.gov)
May 264
Watson W. Mark0001437749-26-018385
SEC(opens sec.gov)
Dec 54
Watson W. Mark0001437749-25-037051
SEC(opens sec.gov)
Jul 314
Watson W. Mark0001437749-25-024250
SEC(opens sec.gov)
Jun 164
Watson W. Mark0001437749-25-020571
SEC(opens sec.gov)
Jun 204
Watson W. Mark0001437749-24-020694
SEC(opens sec.gov)
Jun 124
Watson W. Mark0001437749-24-020095
SEC(opens sec.gov)
Aug 14
Watson W. Mark0001437749-23-021507
SEC(opens sec.gov)
Dec 284
Watson W. Mark0001437749-22-029843
SEC(opens sec.gov)
Aug 84
Watson W. Mark0001437749-22-019446
SEC(opens sec.gov)
Mar 224
Watson W. Mark0001103021-22-000075
SEC(opens sec.gov)

Companies

Address

C/O VAXART, INC. 310 UTAH AVENUE, SUITE 150

SOUTH SAN FRANCISCO, CA, 94080